DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their businesses in Asia, has signed an agreement to provide marketing, sales, logistics, distribution, credit management and -collection services to Pfizer in Laos.
Under the agreement, DKSH has been appointed as the sole Market Expansion Services provider for Pfizer’s entire range of pharmaceutical products in Laos. The agreement is an extension of the successful regional collaboration that also includes Cambodia and Thailand.
“We believe our partnership with DKSH will translate into wider and easier access to our high-quality medicines in Laos, so that more people will benefit from our healthcare innovations. We chose DKSH as it has a well-established nationwide infrastructure in Laos, well-trained local staff and an in-depth understanding of the Lao healthcare market. Moreover, their expertise in marketing and sales as well as their dedication to compliance and quality will mean better services to our valued customers and business partners,” said Pichitchai Jakpaisan, Finance Director and Indochina General Manager, Pfizer Thailand.
“South East Asian markets such as Laos provide extensive opportunities for multinational companies like Pfizer. With our in-depth industry expertise and nearly 20 years’ experience in delivering Market Expansion Services in Laos, we are committed to growing Pfizer’s brand in this market,” commented Kentaro Imamoto, General Manager, Business Unit Healthcare, DKSH Laos.
The agreement strengthens DKSH’s position in Laos while contributing incrementally to the Group’s overall profitability over time.
About Pfizer Inc.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer healthcare products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com
About Pfizer (Thailand) Limited
Established in 1958, Pfizer (Thailand) Ltd. has been advancing efforts to contribute to the health and wellness of the Thai people and the Thai society for 55 years. We work in partnership with public and private organizations, medical professionals and care providers to expand access to our medicines to treat and prevent life-threatening diseases and enhance the health and well-being of Thai people. Like Pfizer colleagues across the globe, Pfizer Thailand is committed to working together for a healthier world. To learn more about us, please visit www.pfizer.co.th
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets.
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 750 business locations in 35 countries – 720 of them in Asia – and 27,600 specialized staff, DKSH generated net sales of CHF 9.8 billion in 2014.
In 2015, DKSH celebrates its 150th anniversary. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia, and is deeply rooted in communities and businesses across Asia Pacific.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration, regulatory services, market entry studies, importation, customs clearance, marketing and sales, physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include pharmaceuticals, consumer health and over-the-counter (OTC) products, as well as medical devices. With 150 business locations in 14 countries and around 9,200 specialized staff, Business Unit Healthcare serves over 150,000 customers and generated net sales of around CHF 4.5 billion in 2014.
Study shines light on the well-being challenges faced by women in healthcare